Tie-2 Antibody Summary
Recombinant full-length protein (Human).
Single pass type I membrane protein.
By immunoblotting, this exhibits no cross-reactivity with recombinant human TIE1.
IgG
Polyclonal
Goat
TEK
Immunogen affinity purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Western Blot 1:100-1:2000
- ELISA 1:100-1:2000
- Functional
ELISA: Use at a concentration of 0.5 – 1.0 ug/ml. Neut: Use at an assay dependent concentration. WB: Use at a concentration of 0.1 – 0.2 ug/ml. Detects a band of approximately 165 kDa. Not tested in other applications.Optimal dilutions/concentrations should be determined by the end user.
Reactivity Notes
Cross-reacts with Human. Not yet tested in other species.
Packaging, Storage & Formulations
Store at -20C. Avoid freeze-thaw cycles.
PBS and 5% Trehalose
No Preservative
0.1 mg/ml
Immunogen affinity purified
Alternate Names for Tie-2 Antibody
- angiopoietin-1 receptor
- CD202b antigen
- CD202b
- EC 2.7.10
- EC 2.7.10.1
- hTIE2
- p140 TEK
- soluble TIE2 variant 1
- soluble TIE2 variant 2
- TEK tyrosine kinase, endothelial
- TEK
- Tie2
- Tie-2
- TIE2CD202b
- Tunica interna endothelial cell kinase
- Tyrosine-protein kinase receptor TEK
- Tyrosine-protein kinase receptor TIE-2
- venous malformations, multiple cutaneous and mucosal
- VMCM
- VMCM1
Background
TIE1/TIE (tyrosine kinase with Ig and EGF homology domains 1) and TIE2/Tek define a new class of the receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EFG) like domains followed by three fibronectin type III like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. Human TIE1 cDNA encodes a 1138 amino acid residue precursor protein with a putative signal peptide, an extracellular domain, and a cytoplasmic domain. Human TIE1/Fc, a disulfide-linked homodimeric protein, has a calculated molecular mass of approximately 107 kDa. Due to glycosylation, the protein migrates to approximately 160 kDa in SDS-PAGE under reducing conditions. TIE1 and TIE2, expressed primarily on endothelial and hematopoietic progenitor cells, play important roles in angiogenesis, vasculogenesis, and hematopoiesis. In developing vascular endothelial cells, TIE1 and TIE2 are specifically expressed. Two ligands that bind TIE have been identified, angiopoietin 1 and angiopoietin 2. Based on gene-targeting studies, the in vivo functions of TIE1 are related to endothelial cell differentiation. The receptor tyrosine kinase TIE also plays a role in the survival and integrity of the endothelium.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets :　Inflammation/Immunology inhibitors